Find a Specialist by Postal Code | Page 7 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Suresh Balasubramian, MD Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jay Yang, MD Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Alain MIna, MD National Cancer Institute - NCI Bethesda Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Mary Armanios, MD Johns Hopkins University Baltimore Maryland United States
Blanche Alter, MD National Cancer Institute - NCI Bethesda Maryland United States
B. Douglas Smith, MD Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Vu Duong, MD University of Maryland Medical Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ivana Gojo Johns Hopkins Medicine Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Neal Young, MD National Heart, Lung, and Blood Institute - National Institutes of Health Bethesda Maryland United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Sharon Savage, MD National Cancer Institute – Shady Grove Rockville Maryland United States
  • Aplastic Anemia
  • Pediatric
Mark Levis, MD, PhD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
Maria Baer, MD University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Sandrine Niyongere, MD University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Andre Larochelle, MD, PhD National Institutes of Health - National Heart, Lung, and Blood Institute Bethesda Maryland United States
Kristen Schratz, MD Johns Hopkins University Baltimore Maryland United States
  • Myelodysplastic Syndromes (MDS)
  • Pediatric
Veronica Dioverti, MD Johns Hopkins University School of Medicine Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Amy E. DeZern, MD, MHS Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
David Steensma, MD, FACP Dana-Farber Cancer Institute Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Akiko Shimamura, MD Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Boston Massachusetts United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Andrew Lane, MD, PhD Dana-Farber Cancer Institute Boston Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)